Yongsheng Wang

Preclinical Evaluation of Chimeric Antigen Receptor–Modified T Cells Specific to Epithelial Cell Adhesion Molecule for Treating Colorectal Cancer

Binglan Zhang, Dan Li, Youling Gong et al. · Human Gene Therapy · 2019 · 89 citations · Full text

Life Sciences, Immunology, Oncology +17

Pyrotinib versus placebo in combination with trastuzumab and docetaxel as first line treatment in patients with HER2 positive metastatic breast cancer (PHILA): randomised, double blind, multicentre, phase 3 trial

Fei Ma, Min Yan, Wěi Li et al. · BMJ · 2023 · 84 citations · Full text

Medicine, Oncology, Pharmacology +17

KRAS G12D mutation predicts lower TMB and drives immune suppression in lung adenocarcinoma

Ge Gao, Wei‐Ting Liao, Qizhi Ma et al. · Lung Cancer · 2020 · 70 citations

Medicine, Genetics, Oncology +16

Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC: Extended Follow-Up of CameL Phase 3 Trial

Caicun Zhou, Gongyan Chen, Yunchao Huang et al. · Journal of Thoracic Oncology · 2023 · 69 citations · Full text

Medicine, Oncology, Pharmacology +11

Liposomal honokiol inhibits VEGF‐D‐induced lymphangiogenesis and metastasis in xenograft tumor model

Jing Wen, A‐fu Fu, Lijuan Chen et al. · International Journal of Cancer · 2008 · 67 citations · Full text

Medicine, Oncology, Pharmacology +17